The primary objective is to evaluate change in renal function over time in kidney transplant recipients who are undergoing OmniGraf monitoring in conjunction with MRSB monitoring. A secondary objective of this study is to identify the impact of OmniGraf use, in conjunction with patient-reported MRSB, as part of clinical care on patient quality of life and patient and graft survival.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.